τ蛋白
微管
SH-SY5Y型
微管相关蛋白
磷酸化
神经母细胞瘤
陶氏病
基因亚型
细胞骨架
细胞生物学
生物
化学
分子生物学
细胞培养
细胞
阿尔茨海默病
生物化学
神经退行性变
内科学
医学
遗传学
基因
疾病
作者
Toshihisa Tanaka,Khalid Iqbal,Ekkhart Trenkner,D. Liu,Inge Grundke‐Iqbal
出处
期刊:FEBS Letters
[Wiley]
日期:1995-02-20
卷期号:360 (1): 5-9
被引量:60
标识
DOI:10.1016/0014-5793(95)00061-d
摘要
In Alzheimer disease (AD) the microtubule associated protein (MAP) tau is hyperphosphorylated at several sites. In the present study, like AD tau, tau in the human neuroblastoma SH‐SY5Y was found to be hyperphosphorylated, at Ser‐199/202, Thr‐231, Ser‐396 and Ser‐404. However, in contrast to AD, the tau in SY5Y cells was not hyperphosphorylated at Ser‐235 and there was only one tau isoform. Quantitative analysis revealed that approximately 80% of the SY5Y‐ tau was phosphorylated at Ser‐199/202. The phosphorylated tau was deposited in perikarya and processes of the cells whereas most of the unphosphorylated (at Ser‐199/202) tau was localized in the nucleus. Tau from the cell lysates did not bind to taxol‐stabilized microtubules. In contrast, MAP1b and MAP2 from cell lysates bound to stabilized microtubules in vitro and were associated to the microtubule network in situ. Phosphorylation of tau at high levels, its inactivity with microtubules and its accumulation in SY5Y cells provide for the first time a cell model of cytoskeletal changes seen in AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI